Adient (ADNT) PT Lowered to $67 at Buckingham Research
Tweet
Share
E-mailGet Alerts ADNT Hot Sheet
Price: $20.59 -0.77%
Rating Summary:
9 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
9 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Buckingham Research lowered its price target on Adient (NYSE: ADNT) to $67.00 (from $74.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Umicore SA (UMI:BB) (UMICY) PT Raised to EUR27 at JPMorgan
- Qualcomm (QCOM) PT Raised to $195 at BofA Securities
- Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Buckingham ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
